You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016

Article info

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Research
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016

Authors

  • Géric Maura Department of Studies in Public Health, French National Health Insurance (Caisse Nationale de l’Assurance Maladie/Cnam), Paris, France University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology - UMR 1219, Bordeaux, France PubMed articlesGoogle scholar articles
  • Cécile Billionnet Department of Studies in Public Health, French National Health Insurance (Caisse Nationale de l’Assurance Maladie/Cnam), Paris, France PubMed articlesGoogle scholar articles
  • Jérôme Drouin Department of Studies in Public Health, French National Health Insurance (Caisse Nationale de l’Assurance Maladie/Cnam), Paris, France PubMed articlesGoogle scholar articles
  • Alain Weill Department of Studies in Public Health, French National Health Insurance (Caisse Nationale de l’Assurance Maladie/Cnam), Paris, France PubMed articlesGoogle scholar articles
  • Anke Neumann Department of Studies in Public Health, French National Health Insurance (Caisse Nationale de l’Assurance Maladie/Cnam), Paris, France PubMed articlesGoogle scholar articles
  • Antoine Pariente University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology - UMR 1219, Bordeaux, France CHU Bordeaux, Bordeaux, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Géric Maura; geric.maura{at}assurance-maladie.fr
View Full Text

Citation

Maura G, Billionnet C, Drouin J, et al
Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016
BMJ Open 2019;9:e026645. doi: 10.1136/bmjopen-2018-026645

Publication history

  • Received September 12, 2018
  • Revised February 4, 2019
  • Accepted February 7, 2019
  • First published April 20, 2019.
Online issue publication 
February 15, 2023
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.